Mice deficient in astrocyte-derived CCL2 have reduced parasite control and decreased immune defense during chronic <i>T</i>. <i>gondii</i> infection. by Stephanie B. Orchanian (17775980)

Transcriptome of splenic myeloid cells from hamsters with VL show proliferative pathways characteristic of cancer diseases. by E. Yaneth Osorio (9226059)

“…<p><b>A</b>, Signaling pathways associated with cell proliferation of tumor cell lines in a set of 278 differentially expressed genes identified in the transcriptome of splenic myeloid cells of hamsters with VL; <b>B</b>, Venn diagram representing a set of 106 differentially expressed genes associated with functions of proliferation of tumor cell lines and growth of tumor; <b>C</b>, Predicted upstream regulators of those 106 differentially expressed genes: Interleukin-4 (IL-4, Z = 2.32), Granulocyte-macrophage colony-stimulating factor = Colony stimulating factor 2 (CSF2, Z = 2.0) and Toll-like receptor 4 (TLR4, Z = 2.32); Orange arrows: lead to activation; blue arrows: lead to inhibition; yellow arrows: conflicting finding; grey arrows undetermined; pink to red gene: increased expression; green gene: decreased expression; <b>D</b>,<b>E</b>, Differentially expressed proto-oncogenes and tumor suppressor genes that lead to cell division of tumoral cells. …”

Expression levels of <i>Alox15</i>, <i>Hmox1</i> and <i>Fth1</i> in pulmonary myeloid cell populations. by Emilie Pollenus (10147748)

Macrophage-specific IGF-1 overexpression decreases plaque MMP8 and. by Patricia Snarski (22305205)

Subjects:

IFNλ does not directly act on neutrophils to decrease bacterial clearance during super-infection. by Danielle Antos (8995433)

Image_3_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Critical Illness.tiff by Shirin Hasan (7894118)

“…There was only a marginal increase in the number of EBIMØ after burn, but, between the signatures of EBIMØ, Siglec-1 expression (MFI) was reduced by 40% in B with and a parallel 44% decrease in TBM erythrons in the BM. There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”

Image_4_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Critical Illness.tiff by Shirin Hasan (7894118)

“…There was only a marginal increase in the number of EBIMØ after burn, but, between the signatures of EBIMØ, Siglec-1 expression (MFI) was reduced by 40% in B with and a parallel 44% decrease in TBM erythrons in the BM. There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”

Image_2_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Critical Illness.tiff by Shirin Hasan (7894118)

“…There was only a marginal increase in the number of EBIMØ after burn, but, between the signatures of EBIMØ, Siglec-1 expression (MFI) was reduced by 40% in B with and a parallel 44% decrease in TBM erythrons in the BM. There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”

Image_1_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Critical Illness.tiff by Shirin Hasan (7894118)

“…There was only a marginal increase in the number of EBIMØ after burn, but, between the signatures of EBIMØ, Siglec-1 expression (MFI) was reduced by 40% in B with and a parallel 44% decrease in TBM erythrons in the BM. There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”

BC2059 inhibits the binding of β-catenin to TBL-1 resulting in decreased β-catenin activity. by Danielle Almeida Braggio (13961252)

Decrease of cyst formation and number of MVs by MLF knock down after the removal of puromycin during vegetative growth using strategy 1. by Zi-Qi Lin (6444350)

CCR2 deficiency attenuates the infiltration of myeloid cells and diminishes the numbers and activation of T cells following <i>C</i>. <i>muridarum</i> respiratory infection. by Shuaini Yang (20670608)

Subjects:

Proinflammatory signaling pathways were decreased in Ad26.COV2.S vaccinated compared to sham unvaccinated hamsters. by Malika Aid (7303874)

Pathways of macrophages and neutrophils were decreased in Ad26.COV2.S vaccinated compared to sham unvaccinated hamsters. by Malika Aid (7303874)

“…Negative correlations were shown in cyan, and positive correlations were shown in pink. (<b>D-K</b>) Myeloid inflammation resolves by 14 days following challenge in vaccinated hamsters. …”

EF-24 treatment significantly reduces cell viability in leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

Image 1_The contribution of BTK signaling in myeloid cells to neuroinflammation.jpeg by Claudia Bassani (7235849)

“…Introduction<p>Bruton’s tyrosine kinase (BTK) is a member of the TEC family of non-receptor tyrosine kinases expressed in cells of hematopoietic origin, including B lymphocytes and myeloid cells. …”

Expression analysis of downstream target genes in the IL-10 signaling pathway across myeloid leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

Identification of TCN as a novel myeloid differentiation inducer. by Souma Suzuki (18554923)

Subjects:

Myeloid knockout <i>VANGL2</i> exacerbates the progression of DSS-induced colitis in mice. by Huaji Jiang (16907514)

Image_1_Myeloid-Derived Suppressor Cells in Lung Transplantation.JPEG by Tobias Heigl (6636725)

“…<p>Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of immune cells from the myeloid lineage. …”